CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
27 hedge funds and large institutions have $5.26M invested in Carisma Therapeutics in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 2 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.04% less ownership
Funds ownership: 0.52% → 0.48% (-0.04%)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $37K
Holders
27
Holding in Top 10
1
Calls
–
Puts
$37K
Top Buyers
| 1 | +$979K | |
| 2 | +$207K | |
| 3 | +$143K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$120K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$65K |
Top Sellers
| 1 | -$343K | |
| 2 | -$268K | |
| 3 | -$102K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$56K |
| 5 |
AL
Airain Ltd
St. Peter Port,
Guernsey
|
-$48K |